Dyne Therapeutics (DYN)
(Delayed Data from NSDQ)
$31.50 USD
+0.56 (1.81%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $31.55 +0.05 (0.16%) 5:42 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.73 | 18.07% |
Earnings Summary
For their last quarter, Dyne Therapeutics (DYN) reported earnings of -$0.81 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for DYN's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.73 per share, reflecting a year-over-year increase of 32.41%.
Earnings History
Price & Consensus
Zacks News for DYN
Zacks Industry Outlook Highlights Dyne Therapeutics, Silence Therapeutics, Alaunos Therapeutics, Assertio Holdings and Acer Therapeutics
DYN: What are Zacks experts saying now?
Zacks Private Portfolio Services